Introduction: Currently, there is no international co-ordinated approach to research into childhood obesity. This is despite much research activity in this area and the universality of the condition. Method: This proposal involves the development of an international register of randomized controlled trials of weight management in overweight and obese children. The primary purpose of the register will be to generate and perform important, focussed prospective meta-analysis of data from trials using the conventional weight management strategies. Prospective metaanalysis is an emerging methodology and has some methodological advantages over retrospective meta-analysis. Proposal: The fundamental initial tasks will be to create scientific interest in the proposal, to identify and co-ordinate Management and Advisory Committees with international membership, to determine and define inclusion and exclusion criteria for trial registration, to define the questions that need to be addressed by prospective meta-analysis and finally to engage investigators to register.
Introduction
Child and adolescent overweight and obesity is increasing worldwide and has serious public health consequences. 1 Effective treatment of childhood overweight and obesity not only improves physical and psychological health during childhood but is an important component of community wide prevention of adult obesity.
The conventional weight-management strategies are the following: reduction in energy intake by dietary means; increase in energy expenditure by increasing physical activity and decreasing sedentary activity; and modification of behaviours and habits associated with eating and activity, all of which include family involvement in the process of behaviour change. 2 Much research has been conducted in this area over many years; however, two systematic reviews of the literature have been unable to produce recommendations for management. 3, 4 This is in part due to the wide variation in setting, population, outcome measures and ways of implementing the weight management strategies. The Cochrane review by Summerbell et al. 4 clearly demonstrates the heterogeneous nature of the research to date. In this review, which included 18 trials, it was not possible to perform conventional meta-analysis of any results due to the differences in the type of intervention and outcome measures reported. In addition, the sample size of each trial was generally small. In conclusion, the authors stated that 'no direct conclusions can be drawn from this review with confidence.' This lack of data was also acknowledged in the WHO Consultation on obesity 5 which stated: 'A much needed research step is to conduct a longitudinal trial that evaluates whether results like those achieved by Epstein and colleagues can be replicated at other sites and in other populations, and whether tangible health benefits, both in the health and social domains, can be demonstrated.' Further, three recently published national guidelines (from Singapore, Scotland and Australia) on the management of obesity in childhood were not able to make a single management recommendation based on the highest level of evidence. 2, 6, 7 One of these national guidelines contained research recommendations which included ; the need for both simple, well designed intervention studies in obese children and adolescents, which can be translated into usual clinical practice; well designed studies to determine the optimal prescriptions for diet, physical activity and reduction in sedentary behaviours in obese children and adolescents; to identify age-appropriate behaviour-modification approaches that promote long-term maintenance of weight control in obese children and adolescents and to identify the role of effective parenting in the treatment approaches to childhood and adolescent obesity. 2 In terms of methodology, data are also lacking about the detail of how to classify and quantify interventions such as change in dietary intake and activity levels as well as how each of these strategies contributes to weight loss when more than one is employed in an overall program of weight management. Consequently, there is a need for ongoing research to determine the minimum effective intervention required to achieve sustainable weight management of childhood obesity. However, since this research will be conducted worldwide where health care systems, cultural influences and available resources will differ, the challenge lies in not only finding statistically and clinically relevant results but widely generalisable results also.
The meta-analysis of randomised controlled trials (of high methodological quality) is usually considered the highest level of evidence for an intervention. 8 Conventionally, meta-analysis is retrospective in the sense that the research question for the meta-analysis is determined or inspired by published trial results. This has led to criticism of this methodology for its potential for bias, particularly publication bias. 9 In addition, results from trials included in the meta-analysis are usually presented as grouped data, limiting the statistical analysis in the meta-analysis to that performed by each trial. The completeness of the meta-analysis depends on the authors conducting a thorough search of the published and unpublished literature to identify potentially eligible trials for inclusion and then having access to the necessary data. Prospective meta-analysis (PMA) is an emerging methodology, which may overcome some of the problems of retrospective meta-analysis. The similarities are that results from individual trials are combined statistically to give greater power. With PMA, eligible trials are identified and enrolled prior to publication of results. This allows an a priori statement of hypotheses, including subgroup analyses. As the protocol for a PMA can be registered and published with the Cochrane Prospective Meta-analysis Methods Group, 10 it is available to potentially inform the design of future trials by stating inclusion criteria related to interventions and outcome measures. One of the authors, DG, is Convener of Cochrane Prospective Meta-analysis Methods Group. Thus researchers may choose to design their new trial so that inclusion criteria for a PMA may be met in addition to meeting the needs of the research hypothesis of the trial. With inclusion of new trials and results over time, data can be reanalysed and published as updates. It is possible that a single trial may contribute to more than one PMA as well as generate results and publications in its own right. The use of individual patient data from each registered trial, rather than pooled data, may allow for more specific and detailed analyses than is usually possible in a retrospective metaanalysis.
In recent years many national and international trial registries have been established, largely with the aim of improving access to current research activities for clinicians, researchers and of course consumers (patients and their families). A further advantage of such registries may be to enhance the conduct of systematic reviews and metaanalysis since all trials of interest should in theory be registered with the coordinating body of the register. If all relevant trials are registered then the potential for publication bias should be minimised since registration obviously must occur prior to or during the conduct of the trials, and hence prior to the publication of results.
This proposal involves the development of an international register of trials of weight management in overweight and obese children. The primary purpose of the register will be to generate and perform important, focussed prospective meta-analyses, so that best available evidence on childhood obesity management is available in a timely manner. Currently, there is no multicentre or integrated approach into childhood obesity research despite much activity in this area. If the method is successful, it would be possible to expand it to include trials of prevention of childhood obesity and ultimately to include other methodologies apart from randomised controlled trials.
Methods
How will the register function? The management committee. The first stage of establishing the Register would be to elect the Management Committee which will be responsible for the overall management of the register and will be comprised of international experts with clinical and research experience in childhood obesity. It is our suggestion that this committee be initially formed by The inaugural Management Committee would be responsible for determining the terms of reference of that committee which would include aims, membership responsibilities, design and implementation of general policies and procedures and specific consideration of the ethical issues pertaining to data use in this manner. This group would need to meet at regular intervals via teleconference or similar technology, as well as by face-to-face meetings. The annual European Congress on Obesity and the North American Association for the Study of Obesity meetings would be appropriate venues as potential members of proposed committees already have established paediatric meetings, including the IOTF Childhood Obesity Programme.
More focussed tasks would be coordinated by Scientific Advisory and Writing Committees. The Writing Committee may have different membership according to topics being addressed by each PMA. These two committees would not be formed until the Management Committee has been created, as one of the tasks of the Management Committee would be to establish the terms of reference of these committees, including how membership is determined. The proposed roles of the management committee are listed in Table 1 .
Registration of trials. In order to reduce heterogeneity in data submitted for meta-analysis, a number of minimum inclusion criteria for registration have been considered. Each trial submitted for registration would need to be assessed by the Scientific Advisory Committee for its ability to meet the inclusion criteria. Missing information would need to be clarified by direct contact with investigators. The proposed minimum inclusion criteria for registration are listed in Table 2 .
Data required following registration. Once registered, trials will be asked to provide more detailed information than that met by the inclusion criteria in order to categorise data for further analysis. This could be in the form of a modified study protocol. The type of detail that will be required could include:
Blinding, randomisation procedure, allocation concealment and intention to treat analysis; Setting for the intervention for example, primary care (general practitioner, primary care paediatrician), community setting (administered by medical or allied health professionals), specialist setting or at a tertiary referral institution (e.g. children's hospital or university); Method of implementation of intervention (e.g. group versus individual); Frequency and duration of intervention.
Depending on the trials registered it may be possible to perform subgroup analysis in PMA which might include age, sex, initial child BMI, initial parent BMI, socioeconomic status and ethnicity. These will differ according to the hypotheses of the PMA. Investigators would be welcome to contribute further baseline data or to nominate what data they have that may be used later.
Implications for investigators with registered trials. Although there will be an Agreement for Collaboration to be signed, it is the intention that registration of trials on this register enhances investigator possibilities for participation in collaborative research in the form of PMA. Investigators maintain autonomy with respect to the amount of data they contribute beyond the minimum inclusion criteria and retain the right to withdraw all data from analysis at any time. The Publication and Authorship policies will be designed to ensure transparency in the publication process. An important component will be the clear right and autonomy of the investigator to always publish individual trial results prior to publication of any combined results in a PMA.
How will a PMA function?. For each PMA a protocol for the study will be written according to guidelines produced by the Cochrane Collaboration Prospective Meta-analysis Methods Group and submitted for publication on the Cochrane Collaboration website. A similar approach to each PMA will be adopted and includes as follows:
Definition of hypothesis; Determination of eligibility criteria (which will usually relate to the intervention details); Determination of Statistical Analysis plan (including power calculation and subgroup analyses); Identification of eligible trials from register; Provision of Publication policy regarding authorship to participating researchers.
Conclusion
This proposed register would provide the opportunity to implement the new methodology of PMA in a field requiring urgent high-quality research. It would also facilitate international collaboration in research while allowing individual investigators to maintain autonomy. The proposed register also provides the potential to provide high-level evidence on methods of weight management in a timely manner.
